All clinical trials are fueled, in part, by optimism. A trial currently underway in California is fueled by the optimism of one patient in particular, Kayvon Goodarzy. Despite decades of effort, there has been an abject lack of new approved therapies for glioblastoma (GBM). The standard of care for this deadly brain tumor has been Read more… Glioblastoma immunotherapy trial: a new breakthrough originally appeared in KevinMD.com.

View Entire Post